Related references
Note: Only part of the references are listed.PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases
Jiang Ni et al.
JOURNAL OF CONTROLLED RELEASE (2021)
BBB pathophysiology-independent delivery of siRNA in traumatic brain injury
Wen Li et al.
SCIENCE ADVANCES (2021)
The in vitro and in vivo properties of ringlike polymer brushes
Changfeng Yin et al.
NANO TODAY (2021)
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Low-Fouling Fluoropolymers for Bioconjugation and In Vivo Tracking
Changkui Fu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers
Divya Gopalan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going
Randy S. D'Amico et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood-brain barrier
Nick Todd et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Contribution of Organofluorine Compounds to Pharmaceuticals
Munenori Inoue et al.
ACS OMEGA (2020)
Rabies Virus-Inspired Metal-Organic Frameworks (MOFs) for Targeted Imaging and Chemotherapy of Glioma
Chaoqiang Qiao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Fluoroalkylation promotes cytosolic peptide delivery
Guangyu Rong et al.
SCIENCE ADVANCES (2020)
In Vivo Tracking of Fluorinated Polypeptide Gene Carriers by Positron Emission Tomography Imaging
Xinyu Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Designing peptide nanoparticles for efficient brain delivery
Aroa Duro-Castano et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery
Ryoma Yokoyama et al.
JOURNAL OF CONTROLLED RELEASE (2020)
A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
Jun Xu et al.
NATURE NANOTECHNOLOGY (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
Garima Sharma et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Fluorine-Containing Drugs Approved by the FDA in 2018
Haibo Mei et al.
CHEMISTRY-A EUROPEAN JOURNAL (2019)
Ferritin drug carrier (FDC) for tumor targeting therapy
Jiuyang He et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Jinbing Xie et al.
BIOMATERIALS (2019)
Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges
Victor M. Pulgar
FRONTIERS IN NEUROSCIENCE (2019)
Length effects of cylindrical polymer brushes on their in vitro and in vivo properties
Zhengkui Zhang et al.
BIOMATERIALS SCIENCE (2019)
Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo
Yu Jiang et al.
ADVANCED MATERIALS (2018)
The fluorination effect of fluoroamphiphiles in cytosolic protein delivery
Zhenjing Zhang et al.
NATURE COMMUNICATIONS (2018)
Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress
Leena S. Knight et al.
NEUROCHEMICAL RESEARCH (2017)
Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials
Yung-Hao Tsou et al.
SMALL (2017)
Enhancing tumor penetration and targeting using size-minimized and zwitterionic nanomedicines
Yajun Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios
Mingming Wang et al.
NATURE COMMUNICATIONS (2014)
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium
Poornima Kolhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface
Y. Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
GAT2/BGT-1 as a system responsible for the transport of γ-aminobutyric acid at the mouse blood-brain barrier
T Takanaga et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Share Paper
